share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

SEC ·  Dec 21 06:10

Summary by Futu AI

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.